This proposal requests funds to upgrade an Illumina Genome Analyzer IIx (GAIIx) to an Illumina HiSeq 2500 (HiSeq 2500). The HiSeq 2500 is a state-of-the-art high-throughput DNA sequencer that has the ability to generate many hundreds of millions of reads per sequencing run. The proposed instrument will be housed and maintained by the Stanford Functional Genomics Facility (SFGF), a service center in the School of Medicine at Stanford University. The facility offers expertise, support, resources, and services for genomics and proteomics based research utilizing microarray technologies and high-throughput sequencing to NIH researchers at Stanford University and other local research institutions. As many investigators have turned to high-throughput sequencing (HTS) for functional genomic studies and will continue to do so in the future, it is critical that the servic center maintain current state-of-the- art instrumentation so that the pioneering research pursued by Stanford researchers can continue. The HTS capabilities of the propose Illumina HiSeq 2500 are required to meet the demands for HTS and give NIH-funded researchers at Stanford University and elsewhere the ability to further understand how our genetic code affects human health and disease.

National Institute of Health (NIH)
Office of The Director, National Institutes of Health (OD)
Biomedical Research Support Shared Instrumentation Grants (S10)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-GGG-L (30))
Program Officer
Birken, Steven
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Stanford University
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Satpathy, Ansuman T; Saligrama, Naresha; Buenrostro, Jason D et al. (2018) Transcript-indexed ATAC-seq for precision immune profiling. Nat Med 24:580-590
Chen, Xingqi; Litzenburger, Ulrike M; Wei, Yuning et al. (2018) Joint single-cell DNA accessibility and protein epitope profiling reveals environmental regulation of epigenomic heterogeneity. Nat Commun 9:4590
Sun, Lu O; Mulinyawe, Sara B; Collins, Hannah Y et al. (2018) Spatiotemporal Control of CNS Myelination by Oligodendrocyte Programmed Cell Death through the TFEB-PUMA Axis. Cell 175:1811-1826.e21
Cho, Seung Woo; Xu, Jin; Sun, Ruping et al. (2018) Promoter of lncRNA Gene PVT1 Is a Tumor-Suppressor DNA Boundary Element. Cell 173:1398-1412.e22
Whitson, Ramon J; Lee, Alex; Urman, Nicole M et al. (2018) Noncanonical hedgehog pathway activation through SRF-MKL1 promotes drug resistance in basal cell carcinomas. Nat Med 24:271-281
Mumbach, Maxwell R; Satpathy, Ansuman T; Boyle, Evan A et al. (2017) Enhancer connectome in primary human cells identifies target genes of disease-associated DNA elements. Nat Genet 49:1602-1612
Rogers, Zoƫ N; McFarland, Christopher D; Winters, Ian P et al. (2017) A quantitative and multiplexed approach to uncover the fitness landscape of tumor suppression in vivo. Nat Methods 14:737-742
Loh, Kyle M; Chen, Angela; Koh, Pang Wei et al. (2016) Mapping the Pairwise Choices Leading from Pluripotency to Human Bone, Heart, and Other Mesoderm Cell Types. Cell 166:451-467